Institutional Ownership Pmv Pharmaceuticals, Inc. (PMVP)
This table provides information about the institutional ownership of Pmv Pharmaceuticals, Inc. (PMVP). We have compiled data on the 83 institutions that hold shares in the stock, with a total of 41.9 Million shares, which have been reported (via 13F filing form) to have a value of $67.9 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
6,475,291
shares
|
$10.9 Million
0.23% of portfolio
|
Q4 2023
Reduced 1.34%
|
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
Nov 14, 2024 Q3 2024 |
3,647,291
shares
|
$6.16 Million
0.08% of portfolio
|
Q3 2024
Added 30.04%
|
|
|
Sio Capital Management, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
3,214,239
shares
|
$5.43 Million
2.53% of portfolio
|
Q3 2024
Added 18.68%
|
|
|
Euclidean Capital LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
2,627,643
shares
|
$4.44 Million
0.43% of portfolio
|
Q3 2023
Added 3.24%
|
|
|
Alkeon Capital Management LLC
New York, NY |
Nov 13, 2024 Q3 2024 |
2,343,731
shares
|
$3.96 Million
0.01% of portfolio
|
Q3 2024
Reduced 0.07%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
2,280,803
shares
|
$3.85 Million
0.0% of portfolio
|
Q3 2024
Reduced 0.06%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
2,078,866
shares
|
$3.51 Million
0.01% of portfolio
|
Q2 2024
Reduced 0.06%
|
|
|
Pfm Health Sciences, LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
2,011,040
shares
|
$3.4 Million
0.18% of portfolio
|
Q3 2024
Added 57.67%
|
|
|
Bml Capital Management, LLC
Zionsville, IN |
Nov 05, 2024 Q3 2024 |
1,688,772
shares
|
$2.85 Million
1.48% of portfolio
|
Q3 2024
Added 28.97%
|
|
|
Interwest Venture Management CO
|
Oct 20, 2023 Q3 2023 |
1,614,911
shares
|
$2.73 Million
48.05% of portfolio
|
Q2 2022
Reduced 50.08%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
1,162,193
shares
|
$1.96 Million
0.0% of portfolio
|
Q2 2024
Reduced 62.63%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
1,055,696
shares
|
$1.78 Million
0.0% of portfolio
|
Q3 2024
Reduced 38.5%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2024 Q3 2024 |
1,040,477
shares
|
$1.76 Million
0.0% of portfolio
|
Q3 2024
Added 2.04%
|
|
|
Oup Management Co., LLC
|
Nov 09, 2023 Q3 2023 |
989,232
shares
|
$1.67 Million
13.66% of portfolio
|
Q4 2021
New holding
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2024 Q3 2024 |
751,200
shares
|
$1.27 Million
0.0% of portfolio
|
Q3 2024
Added 52.22%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Nov 14, 2024 Q3 2024 |
705,593
shares
|
$1.19 Million
0.0% of portfolio
|
Q3 2024
Reduced 9.43%
|
|
|
Personal Cfo Solutions, LLC
|
Nov 14, 2024 Q3 2024 |
550,342
shares
|
$930,077
0.12% of portfolio
|
Q4 2023
Added 57.09%
|
|
|
Citigroup Inc
|
Nov 12, 2024 Q3 2024 |
514,915
shares
|
$870,206
0.0% of portfolio
|
Q3 2024
Reduced 0.14%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
510,004
shares
|
$861,906
0.0% of portfolio
|
Q3 2024
Reduced 36.94%
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
483,055
shares
|
$816,362
0.0% of portfolio
|
Q3 2024
Added 24.4%
|
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Nov 08, 2024 Q3 2024 |
441,024
shares
|
$745,330
0.0% of portfolio
|
Q3 2024
Added 0.43%
|
|
|
Acuitas Investments, LLC
|
Nov 06, 2024 Q3 2024 |
440,687
shares
|
$744,761
0.31% of portfolio
|
Q3 2024
Added 24.58%
|
|
|
Aldebaran Capital, LLC
Indianapolis, IN |
Nov 13, 2024 Q3 2024 |
438,252
shares
|
$740,645
0.6% of portfolio
|
Q3 2024
Added 24.77%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
432,762
shares
|
$731,367
0.0% of portfolio
|
Q3 2024
Added 1.18%
|
|
|
M&T Bank Corp
|
Nov 19, 2024 Q3 2024 |
399,548
shares
|
$675,236
0.0% of portfolio
|
Q3 2024
Added 54.57%
|